Other signaling pathways are implicated in diabetes, such as the mammalian target of Rapamycin (mTOR) in mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2), which appear to be deregulated in the development and progression of diabetes [93]. This evidence concerns the gene MTOR and diabetes mellitus.